Previous 10 | Next 10 |
Mobile Community Clinical Research Facility to be Deployed in California Atlanta, GA - ( NewMediaWire ) - February 15, 2023 - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, and EmVenio Research, a...
This week got off to a wild start, and Tuesday’s volatility from Fed Chair Jerome Powell’s commentary sent markets on a wild ride. While things have settled down a bit, there are still plenty of potential catalysts ahead this week. Many of those events center around central banker s...
Focused on Providing Rapid Response to Combat Emerging Infectious Threats Atlanta, GA - ( NewMediaWire ) - February 08, 2023 - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases,...
Phase 1/2 Trial Now Active at Stanford, Emory, and Thomas Jefferson Universities Atlanta, GA - ( NewMediaWire ) - February 07, 2023 - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious disea...
Phase 1/2 Trial Now Active at Stanford, Emory, and Thomas Jefferson Universities ATLANTA, GA, Feb. 07, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious ...
ATLANTA, GA - ( NewMediaWire ) - January 26, 2023 - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, announced today that its Chairman and CEO, David Dodd, will present at the 2023 BIO CEO & Investor Con...
3 Reasons That Investors Like Penny Stocks Penny stocks are often attractive to investors due to their high volatility, which can lead to large price movements and potentially high returns. This is because penny stocks are typically issued by smaller, less established companies that are m...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Shares of GeoVax (NASDAQ: GOVX ) are shooting to the top of today’s trending ticker list. That’s as GOVX stock is higher by about 60% so far on Wednesday. At today’s high, shares were up almost 100%. ...
Nano cap biotech GeoVax Labs ( NASDAQ: GOVX ) added ~56% on Wednesday after announcing that the U.S. regulators agreed to grant a patent covering its Zika vaccine candidate GEO-ZM02. Specifically, the U.S. Patent and Trademark Office (USPTO) has issued the Notice of Allowance in c...
Preclinical Evaluation Demonstrated 100% Protection Against a Lethal Dose of Zika Virus ATLANTA, GA - ( NewMediaWire ) - January 25, 2023 - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious d...
News, Short Squeeze, Breakout and More Instantly...
ATLANTA, GA - ( NewMediaWire ) - July 11, 2024 - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious diseases, today announced that it has entered into a definitive securities purchase agreement with a cert...
GeoVax Labs, Inc. (NASDAQ: GOVX) is one of today's top gainers. The company's shares have moved 20.05% on the day to $3.02. GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ank...
Award of BARDA Project NextGen contract represents a significant milestone event; total value of award to GeoVax and its CRO partner total approximately $367-388 million BARDA-funded 10,000-participant Phase 2b study will evaluate and compare GeoVax’s ...